Human mesenchymal stem cells (hMSCs) have broad potential uses in tissue engineering and regeneration since they can differentiate along multiple lineages and support hematopoeisis.
Bone marrow derived mesenchymal stem cells (bmMSCs) are widely used for the generation of tissue engineering constructs, since they can differentiate into different cell types occurring in bone tissues.
Funds and hybrid-market approaches can better accompany such co-benefits than markets since they could differentiate rules and criteria for REDD co-benefits without being restricted to the carbon value or by credit buyer preferences.
On the contrary, hematopoietic progenitors are uni-, bi-, or multi-potent since they can differentiate into mature blood cells types [11], but have a limited self-renewal capacity and are therefore transcriptionally unstable in vivo.
These multi-modal projections are interesting since they may differentiate tissuetypes.
These cells presented a clear advantage in this study, since they readily differentiate into cardiomyocytes by embryoid body techniques [13] and bona fide ventricular cardiomyocytes could be easily identified and sorted by FACS analysis through the cardiac specific expression of GFP.
Also the flower peduncles were different compared to wild-types since they did not differentiate a correct abscission zone.
Medium difficulty is psychometrically ideal because items that command very low or very high endorsement are of little diagnostic value since they fail to differentiate between the respondents.
